Navigation Links
Mark G. Watson Named Executive Director of Radiological Society of North America
Date:3/23/2009

OAK BROOK, Ill., March 23 /PRNewswire-USNewswire/ -- The Board of Directors of the Radiological Society of North America (RSNA) is pleased to announce that Mark G. Watson will become the Society's executive director on April 1, 2009. Watson comes to the position with nearly 20 years of experience working in key capacities at RSNA and has served as the Society's interim executive director since September 2008.

Assistant executive director for finance and administration at RSNA for the past 15 years, Watson was selected after a thorough candidate search by Korn/Ferry International in conjunction with RSNA's board of directors and executive director search committee.

"The board's selection of Mark Watson indicates not only its recognition of his history of distinguished service with the RSNA but also its confidence in his ability to provide the good counsel and effective leadership needed to realize the promise of RSNA's future," said Burton P. Drayer, M.D., chairman of the RSNA board of directors.

After graduating from Western Illinois University in Macomb with a bachelor's degree in business and accounting, Watson began his career in 1986 at the KPMG Peat Marwick accounting firm. In 1990, he was hired by RSNA as the director of finance, and two years later became the director of finance and business affairs. In 1994, he became assistant executive director of finance and administration.

During the next 15 years, Watson was responsible for all membership, financial and accounting activities of RSNA, including the development of long-term financial forecasting models that have proved critical to the board's strategic plans and decisions.

He has also been responsible for Society business and administration, including reviewing and negotiating all Society agreements and contracts with outside parties and developing and administering all personnel policies. He was involved in every detail of the development of the RSNA headquarters building, from site selection and financing through construction and move-in. During RSNA management of a number of radiology societies in the 1990s, Watson served as the executive director of the Radiation Research Society and the North American Hyperthermia Society, working closely with the governing boards and committees of these societies and overseeing their administration. In 2005, he was named director of the RSNA Research and Education Foundation.

His depth and breadth of knowledge of RSNA operations and his leadership skills made him the natural candidate for the position of interim executive director.

Colleagues and RSNA board members have long noted Watson's business and financial acumen, as well as his administrative skills.

"He has demonstrated integrity, sound judgment and the ability to make decisions at strategic and operational levels," Dr. Drayer said. "His understanding of and commitment to the RSNA mission, coupled with his genuine affinity for the volunteers and staff who carry it out on a day-to-day basis, have impressed all who have worked with him."

Watson was born in Iowa and has lived in the Chicago area since 1988. He and his wife of 23 years, Annamarie, have two children, Sarah and Matt.

RSNA is an association of more than 42,000 radiologists, radiation oncologists, medical physicists and related scientists committed to excellence in patient care through education and research. The Society is based in Oak Brook, Ill. (RSNA.org)


'/>"/>
SOURCE Radiological Society of North America (RSNA)
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
2. Watson Wyatt Identifies Major Benefit Trends During Open Enrollment Season
3. Texas Affiliates of Susan G. Komen for the Cure, Sen. Kirk Watson, Rep. Patrick Rose, Singer Kelly Willis, Breast Cancer Survivors and Activists Rally for Passage of Proposition 15
4. Watson Files FDA Application for Generic YAZ(R)
5. Watson Names Mark Durand Chief Financial Officer
6. Watson and Novartis Settle Lawsuit Over Exelon(R) Patent Litigation
7. Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement
8. Watson Confirms Patent Litigation With Barr Related to Seasonale(R)
9. Watson Receives FDA Approval for Generic DuoNeb(R)
10. Watson to Distribute Alendronate Tablets
11. Medical Cost Increases to Accelerate Worldwide Over Next Five Years, Watson Wyatt Poll Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... New York (PRWEB) , ... August 23, 2017 , ... ... intellectual and developmental disabilities (I/DD), has launched a groundbreaking LGBTQ community organization for people ... just the first organization of its kind in the state of New Jersey – ...
(Date:8/23/2017)... (PRWEB) , ... August 23, 2017 , ... Jachimowicz ... California, office at 1530 The Alameda, Suite 115. The office is located between Schiele ... the contact information remains the same. Clients can still call the office at 408-246-5500. ...
(Date:8/23/2017)... Texas (PRWEB) , ... August 23, 2017 , ... This ... denied claims firms in Texas. Founded by Bill Voss, the firm grew quickly and ... decade and a half of helping clients get the money they deserve from their ...
(Date:8/23/2017)... ... 2017 , ... Loyale Healthcare today announced the ... joins other recent high-profile hires including Frank Massi, Chief Revenue Officer and Shirley ... helping physician practices and hospitals automate their clinical and financial processes to gain ...
(Date:8/23/2017)... ... 2017 , ... Drs. Steven White and Brad Haines are pleased to announce ... of this offer, valued at more than $300 per year, new patients can enjoy ... patients receive a complimentary professional whitening procedure. , Stained or yellowed tooth enamel ...
Breaking Medicine News(10 mins):
(Date:8/23/2017)... 23, 2017 DarioHealth Corp. (NASDAQ: DRIO), ... health and big data solutions, announced today that ... with domestic and non-U.S. investors for the sale ... shares of the Company,s newly designated Series B ... Current shareholders accounted for 58% of the securities ...
(Date:8/23/2017)... -- Epygenix Therapeutics, Inc., a privately held biopharmaceutical company developing ... epilepsy, announced today that the U.S. Food and Drug ... the treatment of patients with Dravet Syndrome. Dravet Syndrome ... of the Food, Drug, and Cosmetic Act. ... of epilepsy, begins in the first year of life ...
(Date:8/18/2017)... , Aug. 18, 2017  Nortis today announced the awarding of a $688K ... for the third year of a Small Business Innovation ... Institute of Neurological Disorders and Stroke (NINDS).?  ... Nortis ParVivo Chip ... ...
Breaking Medicine Technology: